Diabetes Regional Expert Annual Meeting in the DR [Press Release]

According to the International Diabetes Federation, it is estimated that 425 million people live with diabetes worldwide.

Dr. Ileana Chiari-Shan, Enrique Morales, Hilda Escaño, at DREAM Santo Domingo. dohealthwell.
Dr. Ileana Chiari-Shan, Enrique Morales, Hilda Escaño, at DREAM Santo Domingo. Photo source: AF Comunicacion Estrategica.

Novo Nordisk opens today in Santo Domingo, Dominican Republic, the Diabetes Regional Expert Annual Meeting (DREAM), an innovative scientific event for Central America and the Caribbean whose focus is to transmit the daily life of the people who live with diabetes and taking into account their dreams, desires, and goals.

During this event, important aspects to consider in the management of diabetes will be treated: reduction of cardiovascular risk and prevention of hypoglycemia.

Dr. Ileana Chiari-Shan, medical director of Novo Nordisk, explained that DREAM is a meeting that brings together renowned endocrinologists and diabetologists from Cuba, Panama, Colombia, Mexico, and the Dominican Republic, who will share latest updates in diabetes treatment guidelines.

The guides are an essential component to achieve adequate care of all people with this condition.

The recommendations included define the model of care and based on scientific studies, which are established to prevent, improve control and care of diabetes, in order to guide health professionals, patients, institutions, and health authorities.

This forum, in turn, will encourage a scenario so that experts can put themselves in the shoes of patients and help them fulfill their dreams.

The lecturers of the Diabetes Regional Expert Annual Meeting are Dr. Hilda Escaño, an endocrinologist who represents the Endocrinology Society of the Dominican Republic, and cardiologist Dr. Enrique Morales, from Mexico, who will explain about the integral treatment of type 2 diabetes that includes the prevention of hypoglycemia and reduction of cardiovascular deaths.

Dra. Ileana Chiari-Shan,medical director of Novo Nordisk, hosts the Diabetes Regional Expert Annual Meeting in Santo Domingo.
Dr. Ileana Chiari-Shan, medical director of Novo Nordisk. Source: AF Comunicacion Estrategica.

“Carrying out these medical education initiatives confirms Novo Nordisk commitment in sharing the latest advances in innovative treatments and providing the medical community with updated knowledge that allows people to live with diabetes to achieve a good quality of life and fulfill their dreams, said the medical director.

DREAM was organized by AF Comunicación Estrategica, a firm specializing in consulting of Strategic Communication and Public Relations.

What is diabetes

Diabetes affects 425 million people worldwide and it is estimated that by 2045 it will affect almost 629 million, according to estimates of the International Federation of Diabetes.

The prevalence of diabetes in the countries of Latin America and the Caribbean is growing significantly, and in the case of the Dominican Republic, approximately 13.45% of the population suffers from the disease, according to the study Characterization of type 2 diabetes mellitus in the Dominican Republic, carried out by the National Institute of Diabetes, Endocrinology, and Nutrition (INDEN).

According to the EFRICARD Study II- Study of cardiovascular risk factors and Metabolic syndrome in the Dominican Republic, the prevalence of diabetes was 9.9% and as expected diabetes increased with age; 80% was among 40- 70 years old, which represents the productive age population.

Diabetes worldmap
Source: International Federation of Diabetes.

Based on this study, the main risk factors for cardiovascular death in the Dominican population are hypertension, diabetes, hypercholesterolemia, and obesity.

Diabetes is a condition in which sugar (or glucose) in the blood is found at a high level. This is because the body does not produce or use insulin properly, a hormone that helps cells transform glucose, which comes from food, in energy.

Without enough insulin, glucose stays in the blood and over time, this excess can have serious complications.

Diabetic complications

People with diabetes should undergo periodic screening for possible complications and should be supervised by health professionals.

Among the complications that could occur are hypoglycemia, cardiovascular diseases, blindness, renal failure, and amputations.

Hypoglycemia is a condition characterized by low levels of glucose in the blood abnormal), usually less than 70 mg/dl.

The symptoms of hypoglycemia are important signs that indicate if one has their glucose or sugar levels in the Low blood, some of them are:


  • Sweating
  • Palpitations
  • Shivers
  • Hunger


  • Confusion
  • Dizziness
  • Strange behavior
  • Difficulty in speech
  • Lack of coordination

General discomfort

  • Headache
  • Nausea

Each person reacts to hypoglycemia differently, which is why it is important to recognize your own symptoms when your blood sugar levels are low.

A load of patients with hypoglycemia is much higher in patients with diabetes mellitus type 2.

Frequent causes of hypoglycemia:

  • Excessive insulin dose or error in administration
  • Insufficient consumption of carbohydrates in meals
  • Inadequate synchrony between meals and the use of fast-acting insulins
  • Excessive exercise without adjustment of insulin dose
  • Use of medications with a high risk of hypoglycemia
  • Insufficient glycemic monitoring

Patients who have suffered hypoglycemia are three times more likely to suffer a cardiovascular death.

About 58% of deaths of patients with type 2 diabetes come from a cardiovascular cause.

On average, a 50-year-old individual with diabetes and without a history of cardiovascular disease will die 6 years earlier compared to someone without diabetes.

Type 2 diabetes is also associated with an increased risk of suffering a myocardial infarction.

The incidence of cardiovascular disease increases with age and it varies depending on the country, with the highest rates being observed in low and middle income compared to high-income countries.

About Novo Nordisk

Based in Denmark, Novo Nordisk® is a global company dedicated to healthcare with more than 95 years of innovation and leadership in diabetes care, hemophilia, growth hormone therapy, and obesity.

Novo Nordisk sponsors the Diabetes Regional Expert Annual Meeting in the Dominican Republic. dohealthwell

Novo Nordisk employs approximately 41,400 people in 79 countries and markets its products in more than 165 countries.

DREAM was organized by AF Comunicacion Estrategica, which manages the perception and public projection of its clients before its key audiences, with the aim of positioning its brands, services, and solutions to increase profitability and the recognition of its company before the different interest groups.

Led by Amelia Reyes Mora, who has more than 25 years of experience providing services for multinational and national companies, the firm has a team of specialists in Communication, Public Relations, Marketing, Advertising and event organization.

Press contact of the Diabetes Regional Expert Annual Meeting:

AF Comunicacion Estrategica
Amelia Reyes Mora/Vanessa Durán Marizan
Email: areyes@afcomunicacion.com/vduran@afcomunicacion.com